171 related articles for article (PubMed ID: 34531230)
1. Patient-centered approach to managing factor XIII deficiency.
Iyengar V; Montcrieff C; Pels S
BMJ Case Rep; 2021 Sep; 14(9):. PubMed ID: 34531230
[TBL] [Abstract][Full Text] [Related]
2. Recombinant factor XIII prophylaxis is safe and effective in young children with congenital factor XIII-A deficiency: international phase 3b trial results.
Kerlin BA; Inbal A; Will A; Williams M; Garly ML; Jacobsen L; Kearney SL
J Thromb Haemost; 2017 Aug; 15(8):1601-1606. PubMed ID: 28581691
[TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetic characterization of recombinant factor XIII (FXIII)-A2 across age groups in patients with FXIII A-subunit congenital deficiency.
Brand-Staufer B; Carcao M; Kerlin BA; Will A; Williams M; Tornøe CW; Sandberg Lundblad M; Nugent D
Haemophilia; 2015 May; 21(3):380-385. PubMed ID: 25643920
[TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetics of recombinant factor XIII at steady state in patients with congenital factor XIII A-subunit deficiency.
Kerlin B; Brand B; Inbal A; Halimeh S; Nugent D; Lundblad M; Tehranchi R
J Thromb Haemost; 2014 Dec; 12(12):2038-43. PubMed ID: 25263390
[TBL] [Abstract][Full Text] [Related]
5. Safety and pharmacokinetics of recombinant factor XIII-A2 administration in patients with congenital factor XIII deficiency.
Lovejoy AE; Reynolds TC; Visich JE; Butine MD; Young G; Belvedere MA; Blain RC; Pederson SM; Ishak LM; Nugent DJ
Blood; 2006 Jul; 108(1):57-62. PubMed ID: 16556896
[TBL] [Abstract][Full Text] [Related]
6. Comparison of F13A1 gene mutations in 73 patients treated with recombinant FXIII-A
Ivaškevičius V; Biswas A; Garly ML; Oldenburg J
Haemophilia; 2017 May; 23(3):e194-e203. PubMed ID: 28520207
[TBL] [Abstract][Full Text] [Related]
7. Developing the First Recombinant Factor XIII for Congenital Factor XIII Deficiency: Clinical Challenges and Successes.
Carcao M; Fukutake K; Inbal A; Kerlin B; Lassila R; Oldenburg J; Garly ML; Nugent D
Semin Thromb Hemost; 2017 Feb; 43(1):59-68. PubMed ID: 27556350
[TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetics of recombinant factor XIII in young children with congenital FXIII deficiency and comparison with older patients.
Williams M; Will A; Stenmo C; Rosholm A; Tehranchi R
Haemophilia; 2014 Jan; 20(1):99-105. PubMed ID: 23834599
[TBL] [Abstract][Full Text] [Related]
9. Factor XIII deficiency enhances thrombin generation due to impaired fibrin polymerization - An effect corrected by Factor XIII replacement.
Pitkänen HH; Jouppila A; Lemponen M; Ilmakunnas M; Ahonen J; Lassila R
Thromb Res; 2017 Jan; 149():56-61. PubMed ID: 27902939
[TBL] [Abstract][Full Text] [Related]
10. Real-Life Population Pharmacokinetics of Recombinant Factor XIII and Dosing Considerations for Preventing the Risk of Bleeding in Patients with FXIII Congenital Deficiency.
Cojutti PG; Zanon E; Pasca S; Pea F;
Clin Pharmacokinet; 2022 Apr; 61(4):505-513. PubMed ID: 34718987
[TBL] [Abstract][Full Text] [Related]
11. Safety, pharmacokinetics, and immunogenicity of single-dose rFXIII administration to healthy volunteers.
Reynolds TC; Butine MD; Visich JE; Gunewardena KA; MacMahon M; Pederson S; Bishop PD; Morton KM
J Thromb Haemost; 2005 May; 3(5):922-8. PubMed ID: 15869585
[TBL] [Abstract][Full Text] [Related]
12. Recombinant factor XIII A-subunit in a patient with factor XIII deficiency and recurrent pregnancy loss.
Al-Khabori M; Pathare A; Menegatti M; Peyvandi F
J Thromb Haemost; 2018 Jun; 16(6):1052-1054. PubMed ID: 29665207
[TBL] [Abstract][Full Text] [Related]
13. Biology of Factor XIII and clinical manifestations of Factor XIII deficiency.
Levy JH; Greenberg C
Transfusion; 2013 May; 53(5):1120-31. PubMed ID: 22928875
[TBL] [Abstract][Full Text] [Related]
14. A multicenter, real-world experience with recombinant FXIII for the treatment of patients with FXIII deficiency: from pharmacokinetics to clinical practice. The Italian FXIII Study.
Zanon E; Pasca S; Sottilotta G; Molinari AC; Ferretti A; Di Gregorio P; Pollio B; Pizzuti M; Notarangelo LD; Biasoli C; Cojutti P; Pea F; Simioni P; Peyvandi F
Blood Transfus; 2023 Jul; 21(4):350-355. PubMed ID: 36580025
[TBL] [Abstract][Full Text] [Related]
15. A child with acquired factor XIII deficiency: case report and literature review.
Kessel R; Hu C; Shore-Lesserson L; Rand J; Manwani D
Haemophilia; 2013 Nov; 19(6):814-26. PubMed ID: 23607876
[TBL] [Abstract][Full Text] [Related]
16. Factor XIII deficiency: complete phenotypic characterization of two cases with novel causative mutations.
Katona É; Muszbek L; Devreese K; Kovács KB; Bereczky Z; Jonkers M; Shemirani AH; Mondelaers V; Ermens AA
Haemophilia; 2014 Jan; 20(1):114-20. PubMed ID: 24118344
[TBL] [Abstract][Full Text] [Related]
17. Factor XIII: congenital deficiency factor XIII, acquired deficiency, factor XIII A-subunit, and factor XIII B-subunit.
Tahlan A; Ahluwalia J
Arch Pathol Lab Med; 2014 Feb; 138(2):278-81. PubMed ID: 24476525
[TBL] [Abstract][Full Text] [Related]
18. Efficacy and safety of prophylactic treatment with plasma-derived factor XIII concentrate (human) in patients with congenital factor XIII deficiency.
Ashley C; Chang E; Davis J; Mangione A; Frame V; Nugent DJ
Haemophilia; 2015 Jan; 21(1):102-8. PubMed ID: 25377187
[TBL] [Abstract][Full Text] [Related]
19. Administration of factor XIII B subunit increased plasma factor XIII A subunit levels in factor XIII B subunit knock-out mice.
Souri M; Koseki-Kuno S; Takeda N; Degen JL; Ichinose A
Int J Hematol; 2008 Jan; 87(1):60-8. PubMed ID: 18224415
[TBL] [Abstract][Full Text] [Related]
20. The impact of acquired coagulation factor XIII deficiency in traumatic bleeding and wound healing.
Kleber C; Sablotzki A; Casu S; Olivieri M; Thoms KM; Horter J; Schmitt FCF; Birschmann I; Fries D; Maegele M; Schöchl H; Wilhelmi M
Crit Care; 2022 Mar; 26(1):69. PubMed ID: 35331308
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
